Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08EUS
|
||||
| Former ID |
DNCL003476
|
||||
| Drug Name |
CGC-11047
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Prostate cancer [ICD9: 185; ICD10:C61] | Phase 2 | [1] | ||
| Company |
Progen Pharmaceuticals
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C14H32N4
|
||||
| Canonical SMILES |
CCNCCCNCC=CCNCCCNCC
|
||||
| InChI |
1S/C14H32N4/c1-3-15-11-7-13-17-9-5-6-10-18-14-8-12-16-4-2/h5-6,15-18H,3-4,7-14H2,1-2H3/b6-5-
|
||||
| InChIKey |
XFWLTFZLLXVKDY-WAYWQWQTSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Modulator | [2] | |
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT00585416) Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer. U.S. National Institutes of Health. | ||||
| REF 2 | Gene expression analysis of HCT116 colon tumor-derived cells treated with the polyamine analog PG-11047. Cancer Genomics Proteomics. 2009 May-Jun;6(3):161-75. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.